日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling.

SIRT2 介导的 LCK 去乙酰化控制着 T 细胞受体信号的强度。

Hamaidi Imene, Cheng Pingyan, Jun Soo Young, Manna Alak, Wang Min-Hsuan, Nguyen Anh, Can Ismail, Zhang Min G, Taylor Odesha O, Bailon Luis Uriel Lopez, Fang Bin, Perez Bradford, Creelan Ben C, Marusyk Andriy, Shin Dongjun, Hwang Tae Hyun, Berglund Anders E, Shapiro Virginia S, Ji Haitao M, Conejo-Garcia José R, Kim Sungjune

Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma

开发针对SEMA4A的CAR-T细胞以克服多发性骨髓瘤中BCMA抗原密度低的问题

Francesco Di Meo ,Francesca Albano ,Annamaria Cesarano ,Yunfei Wang ,Brandon Kale ,Kenneth Shain ,Ariosto Silva ,Noriyoshi Kurihara ,Hirofumi Tenshin ,David Jellyman ,Xiaofei Song ,Sasan Ghaffari ,Hector Mesa ,Ben Creelan ,Ciara Freeman ,Xiaohong Zhao ,Mark B Meads ,Paulo C Rodriguez ,Silvia Marino ,Frederick Locke ,Patrick Hwu ,David Roodman ,Jorge Mansilla-Soto ,Fabiana Perna

A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)

奥希替尼联合或不联合雷莫芦单抗治疗酪氨酸激酶抑制剂初治的EGFR突变转移性非小细胞肺癌的多中心开放标签随机II期研究(RAMOSE试验)

Le, Xiuning; Patel, Jyoti D; Shum, Elaine; Baik, Christina; Sanborn, Rachel E; Shu, Catherine A; Kim, Chul; Fidler, Mary Jo; Hall, Richard; Elamin, Yasir Y; Tu, Janet; Blumenschein, George; Zhang, Jianjun; Gibbons, Don; Gay, Carl; Mohindra, Nisha A; Chae, Young; Boumber, Yanis; Sabari, Joshua; Santana-Davila, Rafael; Rogosin, Shane; Herzberg, Benjamin; Creelan, Ben; Pellini, Bruna; Tanvetyanon, Tawee; Heeke, Simon; Hernandez, Mike; Gray, Jhanelle E; Saltos, Andreas; Heymach, John V

Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy

对TIL细胞疗法无反应的转移性非小细胞肺癌患者进行时间序列分析发现,其T细胞和新抗原滞留受损。

Wang, Chao; Yu, Xiaoqing; Teer, Jamie K; Yao, Jiqiang; Du, Dongliang; Liu, Xiaoxian; Thompson, Zachary J; Wang, Min Hsuan; Welsh, Eric A; Memon, Danish; Chan, Timothy A; Makarov, Vladimir; Anadon, Carmen M; Saeed, Lamees; Boyle, Theresa A; Fang, Bin; Koomen, John M; Cox, Cheryl; Landin, Ana M; Yoder, Sean J; Kim, Sungjune; Chen, Dung-Tsa; Pilon-Thomas, Shari A; Conejo-Garcia, Jose R; Antonia, Scott J; Haura, Eric B; Creelan, Benjamin C

Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment

TIL免疫疗法的艺术:SITC对揭开复杂疗法神秘面纱的见解

Turcotte, Simon; Donia, Marco; Gastman, Brian; Besser, Michal; Brown, Robert; Coukos, George; Creelan, Benjamin; Mullinax, John; Sondak, Vernon K; Yang, James C; Rohaan, Maartje W; Marie Svane, Inge; Lotze, Michael T; Haanen, John B A G; Goff, Stephanie L

CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion

CD40L刺激肿瘤浸润B细胞并改善体外TIL扩增

Renata Ariza Marques Rossetti ,Leticia Tordesillas ,Matthew S Beatty ,Junior Cianne ,Elena Martinez Planes ,Dongliang Du ,Sebastian Snedal ,Chao Wang ,Bradford A Perez ,Anders Berglund ,Yian Ann Chen ,Amod Sarnaik ,James J Mulé ,Benjamin Creelan ,Shari Pilon-Thomas ,Daniel Abate-Daga

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

纳武利尤单抗免疫治疗期间新抗原免疫原性图谱和肿瘤生态系统的演变

Alban, Tyler J; Riaz, Nadeem; Parthasarathy, Prerana; Makarov, Vladimir; Kendall, Sviatoslav; Yoo, Seong-Keun; Shah, Rachna; Weinhold, Nils; Srivastava, Raghvendra; Ma, Xiaoxiao; Krishna, Chirag; Mok, Juk Yee; van Esch, Wim J E; Garon, Edward; Akerley, Wallace; Creelan, Benjamin; Aanur, Nivedita; Chowell, Diego; Geese, William J; Rizvi, Naiyer A; Chan, Timothy A

Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial

培加吉胺酶联合一线化疗治疗非上皮样胸膜间皮瘤患者:ATOMIC-Meso随机临床试验

Szlosarek, Peter W; Creelan, Benjamin C; Sarkodie, Thomas; Nolan, Luke; Taylor, Paul; Olevsky, Olga; Grosso, Federica; Cortinovis, Diego; Chitnis, Meenali; Roy, Amy; Gilligan, David; Kindler, Hedy; Papadatos-Pastos, Dionysis; Ceresoli, Giovanni L; Mansfield, Aaron S; Tsao, Anne; O'Byrne, Kenneth J; Nowak, Anna K; Steele, Jeremy; Sheaff, Michael; Shiu, Chiung-Fang; Kuo, Chih-Ling; Johnston, Amanda; Bomalaski, John; Zauderer, Marjorie G; Fennell, Dean A

Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer

一项针对 III 期不可切除非小细胞肺癌患者的 I/II 期研究显示,放疗和化疗联合伊匹木单抗序贯纳武利尤单抗治疗可导致剂量限制性肺毒性。

Liveringhouse, Casey L; Latifi, Kujtim; Asous, Amalin G; Lam, Nghi B; Rosenberg, Stephen A; Dilling, Thomas J; MacMillan, Gretchen V; Chiappori, Alberto A; Haura, Eric B; Creelan, Ben; Gray, Jhanelle E; Tanvetyanon, Tawee; Shafique, Michael R; Saltos, Andreas N; Weiner, Ashley A; Clarke, Jeffrey; Kelsey, Christopher R; Kim, Sungjune; Caudell, James J; Rose, Trevor A; Conejo-Garcia, Jose R; Li, Jiannong; Schell, Michael J; Antonia, Scott J; Perez, Bradford A

Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors

Epacadostat 与 durvalumab 联合治疗转移性实体瘤患者的 1/2 期临床研究

Aung Naing, Alain P Algazi, Gerald S Falchook, Benjamin C Creelan, John Powderly, Seth Rosen, Minal Barve, Niharika B Mettu, Pierre L Triozzi, John Hamm, Gongfu Zhou, Chris Walker, Zhiwan Dong, Manish R Patel2